July 23, 2019
Sinomed enrolls patients to test BuMA Supreme Coronary Drug-Eluting Stent
Sinomed has completed enrollment in the PIONEER III randomized, controlled clinical trial testing the BuMA Supreme DES and support U.S. and Japanese regulatory approvals for the treatment of atherosclerotic coronary lesions.